REFERENCES

1. Goodspeed K, Newsom C, Morris MA, Powell C, Evans P, Golla S. Pitt-Hopkins syndrome: a review of current literature, clinical approach, and 23-patient case series. J Child Neurol 2018;33:233-44.

2. Sweatt JD. Pitt-Hopkins syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. Exp Mol Med 2013;45:e21.

3. Matricardi S, Bonanni P, Iapadre G, et al. Epilepsy, electroclinical features, and long-term outcomes in Pitt-Hopkins syndrome due to pathogenic variants in the TCF4 gene. Eur J Neurol 2022;29:19-25.

4. Zollino M, Zweier C, Van Balkom ID, et al. Diagnosis and management in Pitt-Hopkins syndrome: first international consensus statement. Clin Genet 2019;95:462-78.

5. Watkins A, Bissell S, Moss J, et al. Behavioural and psychological characteristics in Pitt-Hopkins syndrome: a comparison with Angelman and Cornelia de Lange syndromes. J Neurodev Disord 2019;11:24.

6. Tan A, Goodspeed K, Edgar VB. Pitt-Hopkins syndrome: a unique case study. J Int Neuropsychol Soc 2018;24:995-1002.

7. Currò A, Doddato G, Bruttini M, et al. CDKL5 mutations may mimic Pitt-Hopkins syndrome phenotype. Eur J Med Genet 2021;64:104102.

8. Pearson E, Watkins A, Oliver C, Karim A, Clayton-Smith J, Welham A. The adaptive functioning profile of Pitt-Hopkins syndrome. Eur J Med Genet 2021;64:104279.

9. Balkom ID, Vuijk PJ, Franssens M, Hoek HW, Hennekam RC. Development, cognition, and behaviour in Pitt-Hopkins syndrome. Dev Med Child Neurol 2012;54:925-31.

10. Carotenuto M, Roccella M, Pisani F, et al. Polysomnographic findings in fragile x syndrome children with EEG abnormalities. Behav Neurol 2019;2019:5202808.

11. Maini I, Cantalupo G, Turco EC, et al. Clinical and polygraphic improvement of breathing abnormalities after valproate in a case of Pitt-Hopkins syndrome. J Child Neurol 2012;27:1585-8.

12. Kirikae H, Uematsu M, Numata-Uematsu Y, et al. Two types of early epileptic encephalopathy in a Pitt-Hopkins syndrome patient with a novel TCF4 mutation. Brain Dev 2022;44:148-52.

13. Bedeschi MF, Marangi G, Calvello MR, et al. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4. Eur J Med Genet 2017;60:565-71.

14. Laan LA, Vein AA. Angelman syndrome: is there a characteristic EEG? Brain Dev 2005;27:80-7.

15. Kennedy AJ, Rahn EJ, Paulukaitis BS, et al. Tcf4 regulates synaptic plasticity, DNA methylation, and memory function. Cell Rep 2016;16:2666-85.

16. Sepp M, Kannike K, Eesmaa A, Urb M, Timmusk T. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5’ exon usage and splicing. PLoS One 2011;6:e22138.

17. Forrest M, Chapman RM, Doyle AM, Tinsley CL, Waite A, Blake DJ. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Hum Mutat 2012;33:1676-86.

18. Sepp M, Pruunsild P, Timmusk T. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. Hum Mol Genet 2012;21:2873-88.

19. Saby JN, Peters SU, Roberts TPL, Nelson CA, Marsh ED. Evoked potentials and EEG analysis in Rett syndrome and related developmental encephalopathies: towards a biomarker for translational research. Front Integr Neurosci 2020;14:30.